News
|
Message for the patient
Distribution of PolhuminPen injectors
Dear Patients and Doctors, Please be advised that PolhuminPen® injectors are distributed free of charge exclusively as part of a patient program for individuals requiring insulin therapy. To…
Read more
|
Tenders
Request for quotation – RFQZ79/5914/1 – Bioequivalence study: Empagliflozinum, 25 mg, coated tablets
In connection with the implementation of project 2022/ABM/04/00014-00 – “Development and advancement of a medicinal product with the active substance EMPAGLIFLOZIN – a generic drug for type 2…
Read more
|
Message for the patient
Availability of Elenium
Warsaw, October 7, 2025 Dear Sir or Madam, In connection with the administrative decision of the Main Pharmaceutical Inspectorate concerning the withdrawal from the market of specific batches…
Read more